About MyLevel™ Precision Dosing
One-Size-Fits-All Weight Loss Treatment Doesn’t Work.
Most medical weight loss programs use fixed, once-weekly doses of GLP-1 medication. It’s simple, but it assumes everyone’s body responds the same way.
In practice, the same dose can affect people very differently, causing significant side effects in some while failing to adequately control appetite in others.
Until now, there has been no reliable way to identify the precise amount of GLP-1 medication an individual needs or to adjust dosing precisely enough to stay there.
The MyLevel™ Solution
Every patient has a personal medication level where they feel their best and achieve optimal results.
We call this your MyLevel™.
Our patent-pending MyLevel™ app helps identify your ideal MyLevel™ on a simple 0 to 50 scale, then determines the precise dose and dosing interval needed to reach and maintain it.
As your body changes over time, your MyLevel™ can be adjusted up or down to improve appetite control, reduce side effects, or allow greater dietary flexibility.
Standard dosing often leads to unnecessary side effects, inconsistent appetite control, weight loss plateaus, and reduced long-term success.
Personalized dosing with MyLevel™ helps patients experience fewer side effects, maintain steady and predictable appetite control, use less medication to achieve results, lose weight at a pace they choose, and stay in control of their treatment experience.
Curious what your MyLevel™ is?
👉 Book a consultation with one of our providers to get started.
Science nerd…or just bored?
👇 Keep reading for a deeper dive into the hows and whys of MyLevel™ precision dosing.
What Is MyLevel™?
[maɪˈlev.əl] : noun
1 : A precision dosing engine that tracks medication levels and adjusts dosing to keep you in your optimal target range
2 : The “sweet spot” medication level where you experience the fewest side effects and the best results.
Outcomes
We collected and evaluated internal clinic data on 112 patients treated with MyLevel™ dosing adjustments.
We compared each patient’s actual weight loss to what the Phase III trials predict at their exact point in treatment, and their average weekly dose to what the standard protocol would have averaged over that same period.
The trials predicted 10.5% body weight loss. Our patients had lost 13.8% on roughly half the time-matched standard dose.
Semaglutide patients lost an average of 34.7 lbs (16.3%) over 30.8 weeks — about 1.18 lbs/week, more than double the STEP 1 rate of ~0.51 lbs/week. Average dose: 0.71 mg/week vs the time-matched standard of 1.40 mg/week.
Tirzepatide patients lost an average of 25.6 lbs (12.9%) over 22.7 weeks — about 1.21 lbs/week vs the SURMOUNT-1 rate of ~0.73 lbs/week. Average dose: 4.05 mg/week vs the time-matched standard of 7.70 mg/week.
We were not able to identify a single patient that stopped the medication due to side effects.
Patients on MyLevel™ precision dosing lost weight FASTER than the trials would predict and took HALF the medication.
The infographic below tells the story.
Going Deep
This optional section is for readers who want to really understand why and how MyLevel™ works.
We’re going to touch on pharmacokinetics, the study of how medications are absorbed and eliminated by the body.
If that sounds like more detail than you want, feel free to skip.
First Principle.
Doses Create Medication Levels. Levels Are What Matters.
After a medication dose is taken, it does not act immediately. It must first enter the bloodstream, a process known as absorption.
As absorption occurs, the amount of medication active in the body increases. This amount is referred to as your medication level.
Medication levels rise during absorption, reach a peak, then gradually fall as the drug is metabolized and eliminated. If no additional doses are taken, the level eventually returns to zero.
The intensity of both desired effects and side effects is determined by this medication level, not simply by the dose itself.
This process is illustrated in the figure below.
Why Standard GLP-1 Dosing Often Falls Short
Traditional GLP-1 therapy typically follows a fixed weekly dosing schedule with predefined dose escalations. This approach was designed for population-level simplicity, not individual response.
At first glance, it seems reasonable to assume that taking the same dose on the same day each week should result in a consistent experience.
In practice, this assumption breaks down because GLP-1 medications are metabolized very slowly.
It takes roughly one week for the body to eliminate only half of a single GLP-1 dose. Using simple numbers, this means that one week after taking 1 mg of medication, approximately 0.5 mg may still remain in the body.
Another week later, half of that remaining amount is eliminated, and the process continues gradually over several weeks.
The Compounding Effect of Fixed Weekly Dosing
Here is the key insight behind MyLevel™.
If you start from zero and take a dose that produces a peak medication level of 1.0, and one week later there is still 0.5 remaining in your system, the next identical dose does not bring you back to 1.0. It brings you to 1.5.
That is a 50 percent increase in medication level, even though the dose itself did not change.
With each additional identical weekly dose, medication levels continue to rise until equilibrium (also known as “steady state”) is reached, typically after four to five doses.
Five identical doses.
Five different medication levels.
Five different treatment experiences.
It is unlikely that all of these levels feel equally effective or equally tolerable.
Just as equilibrium is reached, standard protocols often instruct patients to increase the dose again, restarting the same cycle of rising levels and unpredictable responses.
The figure below illustrates medication levels over 20 weeks of standard tirzepatide dosing.
Twenty weeks of treatment.
Twenty different medication levels.
It is not surprising that many patients feel uncertain about what to expect from week to week.
Your MyLevel™
We believe that every patient has a personal medication level range where GLP-1 therapy works best.
Within this range, appetite control feels consistent, side effects are manageable, and progress feels sustainable. Outside this range, results often suffer.
MyLevel™ is designed to identify that range and guide dosing decisions that help patients stay within it.
The goal is not continuously higher dosing.
The goal is the right level for you.
How MyLevel™ Guides Dosing Decisions
The MyLevel™ patient-facing app estimates medication levels based on dose history and accumulation, accounts for early, late, or missed doses, and identifies dosing adjustments needed to reach and maintain a target range.
Adjustments occur within physician-defined safety boundaries, allowing treatment to adapt to real life rather than forcing patients into rigid schedules.
If side effects increase or flexibility is needed, the target level can be adjusted downward. If appetite control becomes insufficient, adjustments can be made upward in a controlled and thoughtful manner.
Standard Dosing vs. MyLevel™ Dosing
The standard dosing curve for tirzepatide below shows four weekly doses of 2.5 mg followed by four weekly doses of 5.0 mg.
Medication levels rise with each dose and increase sharply when the dose is escalated from 2.5 mg to 5.0 mg.
Now consider a different approach.
After the first few doses, MyLevel™ identifies the point at which appetite suppression feels ideal and the point at which hunger begins to return. These define the patient’s personal MyLevel™ range.
Levels above this range increase the risk of side effects. Levels below it reduce appetite control. The goal is to remain within this range until a level increase becomes necessary due to adaptation.
Once the range is identified, the MyLevel™ app suggests the exact dose and dosing interval needed to stay there.
Adaptable. Flexible. MyLevel™.
When adaptation occurs, increases are made in small, precise steps. In many cases, raising the target level by a single MyLevel™ unit, one-fiftieth of the full range, is sufficient to overcome plateaus without excessive escalation.
The figure below compares standard escalation with three MyLevel™-guided adjustments.
Better Results With Less Medication
By avoiding unnecessary escalation and excessive peaks, many patients using MyLevel™ achieve comparable or improved weight loss while using less total medication.
This approach often results in fewer side effects, greater consistency, and improved long-term adherence.
When treatment feels predictable and tolerable, patients are more likely to stay engaged and see lasting results.
A final comparison below shows standard dosing versus a MyLevel™-guided approach over a similar 20-week period.
The MyLevel™ App
The screenshots below show examples from the MyLevel™ application, including a patient’s selected MyLevel™, their current estimated medication level, and the calculated dose needed at that moment to reach the target range.
Patients can adjust their MyLevel™ within physician-defined safety limits as needed, while all dosing remains overseen by a licensed physician.
Why MyLevel™ Exists
MyLevel™ was created after observing the same patterns repeatedly, both personally and in patients.
GLP-1 medications are powerful tools, but standard dosing often led to unnecessary side effects, frustration, and early discontinuation. The medication worked, but the dosing strategy was incomplete.
MyLevel™ was built to bring precision, flexibility, and sustainability to GLP-1 therapy.
👉 Book a consultation with one of our providers to get started.
Frequently Asked Questions
Is MyLevel™ only used for GLP-1 medications?
Currently, MyLevel™ is primarily used to guide GLP-1 therapy, though the framework can apply to other medications where accumulation and tolerance matter.
Does MyLevel™ mean lower doses for everyone?
Not necessarily. Some patients require higher medication levels for adequate appetite control. The goal is the right level, not the lowest dose.
How often does dosing change?
Adjustments are made as needed based on response, side effects, and consistency. Many patients stabilize and require fewer changes over time.
Is MyLevel™ automated?
No. MyLevel™ supports clinical decision-making. All dosing is overseen by a licensed physician. Self-adjustment within safe parameters is allowed.
Ready to Learn More?
GLP-1 medications are powerful. How they are dosed makes all the difference.
If your current treatment feels inconsistent or difficult to tolerate, or if you are just now considering starting GLP-1 therapy, MyLevel™ offers a more thoughtful approach.
MyLevel™ precision dosing is only available at Voafit.
👉 Book a consultation to learn how MyLevel™-guided dosing can help you feel better, stay consistent, and get more out of your treatment.
REAL PATIENTS. REAL RESULTS.
Visit here to review real before-and-after photos.